STATE CORPORATION COMMISSION
Bureau of Insurance
April 22, 2020
Administrative Letter-2020-03
TO: All Carriers Licensed to Write Accident and Sickness
Insurance in Virginia, All Health Services Plans and Health Maintenance
Organizations Licensed in Virginia, and Interested Parties
RE: Implementation and Enforcement of House Bill 1503/Senate
Bill 1031 § 38.2-3418.17 of the Code of
Virginia, as Amended
The purpose of this Administrative Letter is to provide
guidance to health carriers regarding the implementation and enforcement of the
above-referenced statute that was amended and reenacted by the 2020 Virginia
General Assembly and that will take effect on January 1, 2021. The Bureau of Insurance (Bureau) is tasked with applying
state law and will enforce all provisions of § 38.2-3418.17 of the Code of
Virginia (Code). The explanation below provides guidance regarding such
enforcement.
Section 38.2-3418.17 of the Code requires coverage for
treatment of autism spectrum disorder (ASD), to include applied behavior
analysis (ABA) services, in the large group market in Virginia. Identical bills
HB 1503/SB 1031 will require such coverage to be extended to policies,
contracts or plans issued, reissued or extended in the individual and small
group markets on or after January 1, 2021, except as limited by certain
subsections.
Virginia's essential health benefits
(EHB) benchmark plan currently excludes ABA services.1 Other
treatment for ASD, to include medically necessary behavioral health treatment,
pharmacy care, psychiatric care, psychological care, and therapeutic care, is
covered under the EHB benchmark plan currently.
Subsection 38.2-3418.17 D of the Code
requires that benefits provided pursuant to this section are not subject to any
visit limits or separate cost sharing. Since this subsection may require an
extension of existing benefits and not additional EHB, the Bureau has
determined that ABA services are the only services required under
§ 38.2-3418.17 of the Code that exceed EHB.
Pursuant to subsection 38.2-3418.17
L, qualified health plans (QHPs) offered through an exchange in the individual
or small group markets are not required to provide the benefits stated in this
section to the extent they exceed EHB. All on-exchange plans (QHPs) generally
are required to be offered and made available off-exchange pursuant to
§ 38.2-3448 of the Code. Therefore, QHPs (with the same plan ID number)
issued off-exchange also are not required to provide benefits that exceed EHB,
i.e., ABA services.
The state, therefore, is not
required to defray costs pursuant to 45 CFR 155.170 since no state mandate
applies to QHPs for ABA services that would be in addition to EHB. Additionally,
the state is not required to defray costs for any QHPs that provide benefits in
accordance with § 38.2-3418.17 of the Code voluntarily, since no state
mandate applies to QHPs (on or off the exchange) for this benefit. Should a QHP
be required to provide ABA services under the Mental Health Parity and
Addiction Equity Act of 2008 (MHPAEA), the state is not required to defray
those benefits pursuant to 45 CFR 155.170.
All non-QHPs providing individual or
group health insurance coverage must provide benefits for treatment of ASD
(including ABA) as stated in § 38.2-3418.17 of the Code. The state is not
responsible to defray any costs related to these requirements for non-QHPs
pursuant to 45 CFR 155.170.
The Bureau offers the following
questions and answers to provide further clarification of its enforcement:
Treatment of Autism Spectrum Disorder FAQs
1. Q: What are the effects of
amendments to § 38.2-3418.17 (HB 1503/SB 1031) in the 2020 General
Assembly session?
A: For Applied Behavior Analysis
(ABA) services: HB 1503/SB 1031 require coverage of ABA services for the
treatment of autism spectrum disorder (ASD) for plans in the individual and
small group markets. The essential health benefits (EHB) checklist indicates
that ABA is excluded in Virginia's EHB benchmark plan. Therefore, the Bureau
has determined that the new application of this section to individual and small
employer group health insurance coverage would require benefits that exceed
EHB.
For other services: HB 1503/SB 1031
require plans in the individual and small group markets to cover treatment of
ASD, to include medically necessary behavioral health treatment, pharmacy care,
psychiatric care, psychological care, and therapeutic care, with no visit
limits. The EHB benchmark plan currently provides these benefits but allows
certain services to be limited. For example, the benchmark plan provides a
minimum for habilitative services of 30 visits per year.
Subsection 38.2-3418.17 L provides
exemption to the benefits required in this section to the extent this section
requires benefits that exceed essential health benefits (EHB) for plans offered
by a carrier through an exchange (qualified health plans or QHPs).
Additionally, Subsection L requires that plans offered outside an exchange
(non-QHPs) comply with the provisions of § 38.2-3418.17.
A QHP is a plan offered through an
exchange but under guaranteed availability provisions that same plan also is
required to be provided off-exchange. A QHP is the same plan whether offered on
or off the exchange, therefore, the off-exchange version also is not required
to provide ABA benefits required by this section. A non-QHP is a plan that is
offered solely off the exchange.
Historically, the Bureau and
Virginia have determined that benefits required that expand an existing EHB are
not considered an "additional required benefit" but rather an
extension of an existing required benefit. Therefore, the requirement in
subsection 38.2-3418.17 D to remove visit limits from coverage provided under
this section can be applied to all individual health insurance coverage and
small employer group health insurance coverage since that does not require an
additional EHB.
In Summary: Non-QHPs must cover all
benefits required by this section. The requirements of this section to cover
ABA services do not apply to QHPs (on and off the exchange) for individual and
small employer group health insurance coverage. The requirement to cover other
treatments listed in this section with no visit limits are required of all QHPs
and non-QHPs. No mandate under this section applicable to QHPs is determined to
be in addition to EHBs, therefore, the state is not required to defray costs.
2. Q: How is ASD defined?
A: According to MHPAEA and per 45
CFR § 146.136 (a), all conditions, including ASD, covered under a plan or
coverage must be defined as either a mental health (MH) or medical/surgical
(M/S) condition. Virginia Code defines ASD, but this definition does not
clearly define ASD as either a MH or M/S condition. Therefore, plans or coverage
must define ASD as either a MH or M/S condition.
3. Q: For large group plans, how are
the requirements of § 38.2-3418.17 applied?
A: If the plan or coverage defines
autism as a M/S condition, then all the requirements in § 38.2-3418.17
apply, including no visit limits, and minimum dollar caps may be applied to ABA
services.
If the plan or coverage defines
autism as a MH condition, the carrier shall not impose visit limits and may be
able to apply the $35,000 minimum dollar cap for ABA benefits per plan year if
compliant with MHPAEA requirements.
4. Q: For individual and small group
plans, what are the requirements for the treatment of ASD?
A: The treatment of ASD is required
under EHBs. The plan must first define ASD as either a M/S condition or a MH
condition and apply all covered treatment as either M/S benefits or MH benefits
(but not both) in accordance with the applicable rules. The plan must provide
benefits in accordance with § 38.2-3418.17 of the Code, except a QHP is
not required to provide benefits for ABA services under this section, unless
required pursuant to MHPAEA.
5. Q: Are there
circumstances under which QHPs in the individual and small group markets are
required to cover ABA?
A: Yes. Coverage for
ABA may be specifically excluded per the EHB benchmark plan, and as explained
above, QHPs are not subject to the requirements of § 38.2-3418.17 to cover ABA.
However, if the carrier defines ASD as a MH condition, then the methodology for
treatment limitations on ABA must be no more restrictive than treatment
limitations on any M/S condition in any given classification under MHPAEA.
6. Q: Can QHPs voluntarily cover
ABA?
A: Yes. ABA treatment consists of a
number of therapy sessions. ABA therapy sessions may be considered habilitative
services, mental health services, or ambulatory patient services, and may be
covered under any of those. Costs associated with the voluntary coverage of ABA
will not be defrayed by the State given that it is determined this mandate does
not apply to QHPs.
7. Q: Can QHPs that voluntarily
cover ABA therapy visits under habilitative services still impose the $35,000
or 30-visit limit?
A: Possibly, since ABA benefits are
not EHB and are not required to be offered by QHPs pursuant to
§ 38.2-3418.17 of the Code, a carrier may place a dollar or visit limit on
ABA services. However, if the carrier defines the condition for which the ABA
therapy is being used to treat as a MH condition, then MHPAEA calculation
requirements apply and it is possible this would require no dollar limit, a
revised dollar limit, or visits limits to be increased or unlimited.
8. Q: If compliance
with MHPAEA requires a carrier to exceed EHB benchmark limits, must the state
defray the cost?
A: No. Compliance
with MHPAEA does not require defrayal of cost.
This letter describes and summarizes
the requirements of § 38.2-3418.17 of the Code. The provisions of which
should be reviewed carefully for compliance.
Any questions concerning this
Administrative Letter may be addressed to: Brant Lyons, Senior Insurance Market
Examiner, Life & Health Division, Bureau of Insurance, telephone (804)
371-9490, or email brant.lyons@scc.virginia.gov.
/s/ Scott A. White
Commissioner of Insurance
_______________________________
1See https://scc.virginia.gov/getattachment/0c71fa06-32c4-47cf-a4f9-313bf059230c/ehbfillin.pdf
DEPARTMENT OF MEDICAL ASSISTANCE SERVICES
Draft Pharmacy Appendix D for
Stakeholder Input
Comment period: May 1, 2020, to May 31, 2020.
The draft Appendix D of the Pharmacy
provider manual is now available on the Department of Medical Assistance
Services (DMAS) website at http://www.dmas.virginia.gov/#/manualdraft for public comment until May 31, 2020.
The Pharmacy provider manual update
reflects updates to the Virginia Medicaid's fee-for-service Preferred Drug List
program and drug service authorization requirements for drugs reviewed by the
DMAS Pharmacy and Therapeutics Committee and the Drug Utilization Review Board.
Contact Information: Emily McClellan, Regulatory Manager, Division of Policy
and Research, Department of Medical Assistance Services, 600 East Broad Street,
Suite 1300, Richmond, VA 23219, telephone (804) 371-4300, FAX (804) 786-1680,
TDD (800) 343-0634, or email emily.mcclellan@dmas.virginia.gov.
STATE WATER CONTROL BOARD
Proposed Consent Special Order for the City of Covington
An enforcement action has been proposed for the City of
Covington for violations in Covington, Virginia. The State Water Control Board
proposes to issue a special order by consent to the City of Covington to
address noncompliance with the State Water Control Law and regulations. A
description of the proposed action is available at the Department of
Environmental Quality office listed or online at www.deq.virginia.gov.
Nelson Dail will accept comments by email at nelson.dail@deq.virginia.gov
or by postal mail at Department of Environmental Quality, Blue Ridge Office,
901 Russell Drive, Salem, VA 24153, from May 25, 2020, to June 25, 2020.
Proposed Consent Order for Virginia Black Granite Inc.
An enforcement action has been proposed for Virginia Black
Granite Inc. for violations of the State Water Control Law and regulations at
the Virginia Black Granite facility located in Rapidan, Virginia. The State
Water Control Board proposes to issue a consent order to resolve violations
associated with the Virginia Black Granite facility. A description of the
proposed action is available at the Department of Environmental Quality office
listed or online at www.deq.virginia.gov. Benjamin Holland
will accept comments by email at benjamin.holland@deq.virginia.gov, or by postal mail at
Department of Environmental Quality, Northern Regional Office, 13901 Crown
Court, Woodbridge, VA 22193, from May 26, 2020, through June 25, 2020.
VIRGINIA CODE COMMISSION
Notice to State Agencies
Contact Information: Mailing
Address: Virginia Code Commission, Pocahontas Building, 900 East Main
Street, 8th Floor, Richmond, VA 23219; Telephone: (804) 698-1810; Email:
varegs@dls.virginia.gov.
Meeting Notices: Section 2.2-3707 C of the Code of
Virginia requires state agencies to post meeting notices on their websites and
on the Commonwealth Calendar at https://commonwealthcalendar.virginia.gov.
Cumulative Table of Virginia Administrative Code Sections
Adopted, Amended, or Repealed: A table listing regulation sections that
have been amended, added, or repealed in the Virginia Register of
Regulations since the regulations were originally published or last
supplemented in the print version of the Virginia Administrative Code is
available at http://register.dls.virginia.gov/documents
/cumultab.pdf.
Filing Material for Publication in the Virginia Register
of Regulations: Agencies use the Regulation Information System (RIS) to
file regulations and related items for publication in the Virginia Register
of Regulations. The Registrar's office works closely with the Department of
Planning and Budget (DPB) to coordinate the system with the Virginia Regulatory
Town Hall. RIS and Town Hall complement and enhance one another by sharing
pertinent regulatory information.
ERRATA
STATE CORPORATION COMMISSION
Title of Regulation: 14VAC5-300.
Rules Governing Credit for Reinsurance.
Publication: 36:19 VA.R.
2172-2186 May 11, 2020.
Correction to Agency Contact:
Page 2172, column 1, after "telephone" change
"(804) 371-9152" to "(804) 371-9499"
VA.R. Doc. No. R20-6333; Filed May 12, 2020, 12:18 p.m.